{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:29:19Z","timestamp":1774690159244,"version":"3.50.1"},"reference-count":41,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Feline cardiogenic arterial thromboembolism (ATE) is a severe complication of cardiac disease in cats, often causing severe clinical signs and poor prognosis. Despite its importance, standardized guidelines for prevention and treatment are lacking. This systematic review evaluated available evidence on preventive, acute, and chronic management strategies for feline cardiogenic ATE. A comprehensive search using PubMed, Scopus and Web of Science was performed, following PRISMA 2020 guidelines. Peer-reviewed studies investigating therapeutic interventions for ATE were included. Risk of bias was assessed using the SYRCLE tool. Nineteen studies involving 909 cats were included. Preventive therapy with clopidogrel and rivaroxaban improved survival. Acute multimodal treatment combining anticoagulant and antiplatelet drugs improved survival compared to monotherapy. Thrombolytic therapy showed some efficacy but had frequent severe complications. Long-term management with clopidogrel and rivaroxaban achieved the longest survival and lowest recurrence, while acetylsalicylic acid provided inconsistent benefits and more adverse effects. Eleven of the nineteen (58%) studies had high risk of bias due to small sample size and heterogeneous protocols. Current evidence supports dual therapy, particularly clopidogrel with rivaroxaban or enoxaparin, as the most effective and well-tolerated approach for prevention and treatment. Larger, standardized prospective trials are urgently needed to strengthen the evidence.<\/jats:p>","DOI":"10.3390\/ani15243539","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T09:02:50Z","timestamp":1765270970000},"page":"3539","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment and Prevention of Cardiogenic Arterial Thromboembolism in the Cat: A Systematic Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5674-0112","authenticated-orcid":false,"given":"Giulia","family":"Arcuri","sequence":"first","affiliation":[{"name":"Department of Animal Medicine, Production & Health, University of Padova, Viale dell\u2019Universit\u00e0 16, 35020 Legnaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Bresolin","sequence":"additional","affiliation":[{"name":"Department of Animal Medicine, Production & Health, University of Padova, Viale dell\u2019Universit\u00e0 16, 35020 Legnaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7575-3646","authenticated-orcid":false,"given":"Carlo","family":"Guglielmini","sequence":"additional","affiliation":[{"name":"Department of Animal Medicine, Production & Health, University of Padova, Viale dell\u2019Universit\u00e0 16, 35020 Legnaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1098612X241257878","DOI":"10.1177\/1098612X241257878","article-title":"Feline Aortic Thromboembolism: Recent Advances and Future Prospects","volume":"26","author":"Guillaumin","year":"2024","journal-title":"J. Feline Med. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/j.jvc.2015.10.004","article-title":"Secondary Prevention of Cardiogenic Arterial Thromboembolism in the Cat: The Double-Blind, Randomized, Positive-Controlled Feline Arterial Thromboembolism; Clopidogrel vs. Aspirin Trial (FAT CAT)","volume":"17","author":"Hogan","year":"2015","journal-title":"J. Vet. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cvsm.2023.06.002","article-title":"Preventing Cardiogenic Thromboembolism in Cats: Literature Gaps, Rational Recommendations, and Future Therapies","volume":"53","author":"Shaverdian","year":"2023","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1177\/1098612X221135105","article-title":"Bilateral Lysis of Aortic Saddle Thrombus with Early Tissue Plasminogen Activator (BLASTT): A Prospective, Randomized, Placebo-Controlled Study in Feline Acute Aortic Thromboembolism","volume":"24","author":"Guillaumin","year":"2022","journal-title":"J. Feline Med. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jvim.12249","article-title":"Arterial Thromboembolism in 250 Cats in General Practice: 2004\u20132012","volume":"28","author":"Borgeat","year":"2014","journal-title":"J. Vet. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cvsm.2017.05.001","article-title":"Feline Cardiogenic Arterial Thromboembolism: Prevention and Therapy","volume":"47","author":"Hogan","year":"2017","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4314\/ovj.v10i3.13","article-title":"Feline Aortic Thromboembolism: Presentation, Diagnosis, and Treatment Outcomes of 15 Cats","volume":"10","author":"Hassan","year":"2020","journal-title":"Open Vet. J."},{"key":"ref_8","first-page":"73","article-title":"Arterial Thromboembolism in Cats: Acute Crisis in 127 Cases (1992-2001) and Long-Term Management with Low-Dose Aspirin in 24 Cases","volume":"17","author":"Smith","year":"2003","journal-title":"J. Vet. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1177\/1098612X221123770","article-title":"Ultrasonographic Findings of Feline Aortic Thromboembolism","volume":"24","author":"Lurier","year":"2022","journal-title":"J. Feline Med. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2460\/javma.24.09.0584","article-title":"Therapy with Clopidogrel or Rivaroxaban Has Equivalent Impacts on Recurrence of Thromboembolism and Survival in Cats Following Cardiogenic Thromboembolism: The SUPERCAT Study","volume":"263","author":"Brainard","year":"2024","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1098612X211013736","article-title":"Dual Therapy with Clopidogrel and Rivaroxaban in Cats with Thromboembolic Disease","volume":"24","author":"Lo","year":"2022","journal-title":"J. Feline Med. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1939-1676.2006.tb02831.x","article-title":"Assessment of Left Atrial Appendage Flow Velocity and Its Relation to Spontaneous Echocardiographic Contrast in 89 Cats with Myocardial Disease","volume":"20","author":"Schober","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_13","first-page":"S318","article-title":"Risk Factors Associated with Sudden Death vs","volume":"17","author":"Payne","year":"2015","journal-title":"Congestive Heart Failure or Arterial Thromboembolism in Cats with Hypertrophic Cardiomyopathy. J. Vet. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.14202\/vetworld.2024.796-803","article-title":"Rivaroxaban versus Enoxaparin plus Clopidogrel Therapy for Hypertrophic Cardiomyopathy-Associated Thromboembolism in Cats","volume":"17","author":"Jaturanratsamee","year":"2024","journal-title":"Vet. World"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2460\/javma.2004.225.1237","article-title":"Use of Low Molecular Weight Heparin in Cats: 57 Cases (1999\u20132003)","volume":"225","author":"Smith","year":"2004","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jvim.15745","article-title":"ACVIM Consensus Statement Guidelines for the Classification, Diagnosis, and Management of Cardiomyopathies in Cats","volume":"34","author":"Abbott","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/vec.12795","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 3-Defining Antithrombotic Protocols","volume":"29","author":"Blais","year":"2019","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/vec.12791","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 2-Defining Rational Therapeutic Usage","volume":"29","author":"Goggs","year":"2019","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/vec.12794","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 4-Refining and Monitoring Antithrombotic Therapies","volume":"29","author":"Sharp","year":"2019","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 Explanation and Elaboration: Updated Guidance and Exemplars for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., de Vries, R.B., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s Risk of Bias Tool for Animal Studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jfms.1999.0049","article-title":"Feline Distal Aortic Thromboembolism: A Review of 44 Cases (1990\u20131998)","volume":"1","author":"Schoeman","year":"1999","journal-title":"J. Feline Med. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1476-4431.2000.tb00010.x","article-title":"Retrospective Study of Streptokinase Administration in 46 Cats with Arterial Thromboembolism","volume":"10","author":"Moore","year":"2000","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1939-1676.2006.tb02859.x","article-title":"Use of Rheolytic Thrombectomy in the Treatment of Feline Distal Aortic Thromboembolism","volume":"20","author":"Reimer","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jfms.2009.08.001","article-title":"Prospective Evaluation of Tissue Plasminogen Activator in 11 Cats with Arterial Thromboembolism","volume":"12","author":"Welch","year":"2010","journal-title":"J. Feline Med. Surg."},{"key":"ref_26","first-page":"149","article-title":"Comparison Between a Continuous Rate Infusion Protocol and an Accelerated Dosing Protocol Using Tissue Plasminogen Activator for Thrombolysis in Cats and Dogs","volume":"16","author":"Oh","year":"2018","journal-title":"Int. J. Appl. Res. Vet. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1098612X18778157","article-title":"Thrombolysis with Tissue Plasminogen Activator (TPA) in Feline Acute Aortic Thromboembolism: A Retrospective Study of 16 Cases","volume":"21","author":"Guillaumin","year":"2019","journal-title":"J. Feline Med. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.56808\/2985-1130.3012","article-title":"Survival Time and Factors Influencing Survival Time in Cats with Arterial Thromboembolism in Thailand","volume":"50","author":"Surachetpong","year":"2020","journal-title":"Thai J. Vet. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/23144599.2021.1982335","article-title":"Usefulness of Peripheral Venous Blood Gas Analyses in Cats with Arterial Thromboembolism","volume":"9","author":"Tosuwan","year":"2021","journal-title":"Int. J. Vet. Sci. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mitropoulou, A., Hassdenteufel, E., Lin, J., Bauer, N., Wurtinger, G., Vollmar, C., Henrich, E., Hildebrandt, N., and Schneider, M. (2022). Retrospective Evaluation of Intravenous Enoxaparin Administration in Feline Arterial Thromboembolism. Animals, 12.","DOI":"10.3390\/ani12151977"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jvc.2022.02.006","article-title":"Clinical Use of Tissue Plasminogen Activator for Systemic Thrombolysis in Dogs and Cats","volume":"41","author":"Diaz","year":"2022","journal-title":"J. Vet. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-Bias VISualization (Robvis): An R Package and Shiny Web App for Visualizing Risk-of-Bias Assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejvs.2019.09.006","article-title":"Editor\u2019s Choice\u2014European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia","volume":"59","author":"Earnshaw","year":"2020","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1185\/03007995.2016.1163256","article-title":"Meta-Analysis and Adjusted Indirect Comparison of Direct Oral Anticoagulants in Prevention of Acute Limb Ischemia in Patients with Atrial Fibrillation","volume":"32","author":"Bleda","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Dimitriadis, K., Adamopoulou, E., Pyrpyris, N., Iliakis, P., Beneki, E., Konstantinidis, D., Fragkoulis, C., Antonopoulos, A., Papanikolaou, A., and Aznaouridis, K. (2025). Combined Catheter Ablation and Left Atrial Appendage Occlusion in Atrial Fibrillation: From Data to Clinical Reality. Cardiovasc. Drugs Ther., 1\u201332.","DOI":"10.1007\/s10557-025-07685-2"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Katsanos, K., Spiliopoulos, S., Saha, P., Diamantopoulos, A., Karunanithy, N., Krokidis, M., Modarai, B., and Karnabatidis, D. (2015). Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135692"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yeh, N.S., Shaverdian, M., and Li, R.H.L. (2025). Evolving FATE: A New Lens on the Pathogenesis and Management of Feline Cardiogenic Arterial Thromboembolism. Animals, 15.","DOI":"10.20944\/preprints202505.2251.v1"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/vec.13227","article-title":"2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining Rational Use of Thrombolytics","volume":"32","author":"Sharp","year":"2022","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases: Developed by the Task Force on the Management of Peripheral Arterial and Aortic Diseases of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), and the European Society of Vascular Medicine (ESVM)","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur. Heart. J."},{"key":"ref_41","first-page":"5896","article-title":"Streptokinase or Alteplase for Acute Limb Ischemia? A Meta-Analysis","volume":"9","author":"Suwirya","year":"2025","journal-title":"Biosci. Med. J. Biomed. Transl. Res."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/15\/24\/3539\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T05:29:29Z","timestamp":1765344569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/15\/24\/3539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":41,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ani15243539"],"URL":"https:\/\/doi.org\/10.3390\/ani15243539","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}